About 1-[[5-[3-[2-bromo-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methoxypyrazin-2-yl]phenyl]-2-fluorophenyl]-3-methoxypyrazin-2-yl]methyl]azetidin-3-ol
1-[[5-[3-[2-bromo-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methoxypyrazin-2-yl]phenyl]-2-fluorophenyl]-3-methoxypyrazin-2-yl]methyl]azetidin-3-ol (PubChem CID 139429861) has the molecular formula C30H30BrFN6O4
and a molecular weight of 637.51 g/mol. Its IUPAC name is 1-[[5-[3-[2-bromo-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methoxypyrazin-2-yl]phenyl]-2-fluorophenyl]-3-methoxypyrazin-2-yl]methyl]azetidin-3-ol.
Molecular Properties
| Compound Name | 1-[[5-[3-[2-bromo-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methoxypyrazin-2-yl]phenyl]-2-fluorophenyl]-3-methoxypyrazin-2-yl]methyl]azetidin-3-ol |
| PubChem CID | 139429861 |
| Molecular Formula | C30H30BrFN6O4 |
| Molecular Weight | 637.51 g/mol |
| Exact Mass | 636.15 |
| IUPAC Name | 1-[[5-[3-[2-bromo-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methoxypyrazin-2-yl]phenyl]-2-fluorophenyl]-3-methoxypyrazin-2-yl]methyl]azetidin-3-ol |
| SMILES | COc1nc(-c2cccc(-c3cccc(-c4cnc(CN5CC(O)C5)c(OC)n4)c3Br)c2F)cnc1CN1CC(O)C1 |
| InChI | InChI=1S/C30H30BrFN6O4/c1-41-29-25(15-37-11-17(39)12-37)33-9-23(35-29)21-7-3-5-19(27(21)31)20-6-4-8-22(28(20)32)24-10-34-26(30(36-24)42-2)16-38-13-18(40)14-38/h3-10,17-18,39-40H,11-16H2,1-2H3 |
| InChIKey | PTZQHKKCROFVKZ-UHFFFAOYSA-N |
| XLogP | 3.54 |
| TPSA | 116.96 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 637.51 |
| LogP ≤ 5 | 3.54 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Analyze 1-[[5-[3-[2-bromo-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methoxypyrazin-2-yl]phenyl]-2-fluorophenyl]-3-methoxypyrazin-2-yl]methyl]azetidin-3-ol with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 1-[[5-[3-[2-bromo-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methoxypyrazin-2-yl]phenyl]-2-fluorophenyl]-3-methoxypyrazin-2-yl]methyl]azetidin-3-ol?
The IUPAC name of 1-[[5-[3-[2-bromo-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methoxypyrazin-2-yl]phenyl]-2-fluorophenyl]-3-methoxypyrazin-2-yl]methyl]azetidin-3-ol (CID 139429861) is 1-[[5-[3-[2-bromo-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methoxypyrazin-2-yl]phenyl]-2-fluorophenyl]-3-methoxypyrazin-2-yl]methyl]azetidin-3-ol.
What is the SMILES notation for 1-[[5-[3-[2-bromo-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methoxypyrazin-2-yl]phenyl]-2-fluorophenyl]-3-methoxypyrazin-2-yl]methyl]azetidin-3-ol?
The canonical SMILES for 1-[[5-[3-[2-bromo-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methoxypyrazin-2-yl]phenyl]-2-fluorophenyl]-3-methoxypyrazin-2-yl]methyl]azetidin-3-ol is COc1nc(-c2cccc(-c3cccc(-c4cnc(CN5CC(O)C5)c(OC)n4)c3Br)c2F)cnc1CN1CC(O)C1.
What is the InChIKey of 1-[[5-[3-[2-bromo-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methoxypyrazin-2-yl]phenyl]-2-fluorophenyl]-3-methoxypyrazin-2-yl]methyl]azetidin-3-ol?
The InChIKey is PTZQHKKCROFVKZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H30BrFN6O4/c1-41-29-25(15-37-11-17(39)12-37)33-9-23(35-29)21-7-3-5-19(27(21)31)20-6-4-8-22(28(20)32)24-10-34-26(30(36-24)42-2)16-38-13-18(40)14-38/h3-10,17-18,39-40H,11-16H2,1-2H3.
What are the key properties of 1-[[5-[3-[2-bromo-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methoxypyrazin-2-yl]phenyl]-2-fluorophenyl]-3-methoxypyrazin-2-yl]methyl]azetidin-3-ol?
1-[[5-[3-[2-bromo-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methoxypyrazin-2-yl]phenyl]-2-fluorophenyl]-3-methoxypyrazin-2-yl]methyl]azetidin-3-ol has a molecular weight of 637.51 g/mol, XLogP of 3.54, 9 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[[5-[3-[2-bromo-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methoxypyrazin-2-yl]phenyl]-2-fluorophenyl]-3-methoxypyrazin-2-yl]methyl]azetidin-3-ol is sourced from PubChem (CID 139429861), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).